SOD1 and hypertensive disorder: Treatment with the SOD mimetic tempol reduces vascular ROS and lower blood pressure in animal models of essential and secondary hypertension [253,257,269,317,402,403,404], of diabetes [405,406,407,408], and of preeclampsia [293,294,346,409].